Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:35187044

CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression.

Yong Xiao · Kun Yang · Zhen Wang · Mengjie Zhao · Yanxiang Deng · Wei Ji · Yuanjie Zou · Chunfa Qian · Yong Liu · Hong Xiao · Hongyi Liu

Frontiers in surgery · 2021 doi:10.3389/fsurg.2021.775194

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:35187044
kind
science-record
content_hash
sha256:38ef21178018406a53c57c7d197b1d577c3e2aa66ea6dbe03585fbbd3fc5f2f3
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T17:36:57Z
updated_at
2026-11-01T22:48:32Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression.
doi
10.3389/fsurg.2021.775194
pmid
35187044
authors array · 11 items
[0]
Yong Xiao
[1]
Kun Yang
[2]
Zhen Wang
[3]
Mengjie Zhao
[4]
Yanxiang Deng
[5]
Wei Ji
[6]
Yuanjie Zou
[7]
Chunfa Qian
[8]
Yong Liu
[9]
Hong Xiao
[10]
Hongyi Liu
journal
Frontiers in surgery
year
2021
abstract
BACKGROUND: Glioma is the most common primary brain tumor with a poor prognosis. Key genes that are negatively related to prognosis may provide the therapy targets to cure glioma. To clarify the role of CD44 in glioma, we explored its function at bulk-transcriptome, spatial and single-cell transcriptome levels. METHODS: In total, expression profiles with survival data of whole-grade glioma from The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA), RNA-seq data with anatomic information of glioblastoma (GBM) from the Ivy Glioblastoma Atlas Project, RNA-sequencing (RNA-seq) data from recurrent GBM receiving adjuvant anti-PD-1 immunotherapy accessed through GSE121810, and single-cell RNA-seq data of GBM under accession GSE103224 were enrolled in this study. CD44-specific findings were further analyzed by R language. RESULTS: CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma. Meanwhile, CD44 predominantly expresses in GBM mesenchymal subtype, and gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses reveal that CD44 positively coexpressed genes are closely related to glioma immunity. Moreover, CD44+ cells mainly distribute in perinecrotic region with high expression of immune factors. At single-cell resolution, only malignant tumor cells, tumor-associated macrophages (TAMs), and T cells express CD44 in GBM. CD44+ malignant tumor cells are in mesenchymal-1-like (MES1-like) cellular state, and CD44+ TAMs are in M2 phenotype. CD44+ T cells have high expression of both PD-1 and PD-L1. CD44 and its directly interacted inhibitory immunomodulators are upregulated in patients with nonresponder recurrent GBM treated with PD-1 blockade therapy. CONCLUSION: Our work demonstrates that CD44, a new M2 TAM biomarker, is involved in immune suppressor and promote glioma progression in glioma microenvironment. These results expand our understanding of CD44-specific clinical and immune features in glioma.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35187044
locator
sections[4] "Survival Analysis" paragraph 2
quote
Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35187044
locator
sections[23] "Data Availability Statement" paragraph 2
quote
Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma.
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35187044
locator
sections[0] "Abstract" paragraph 3
quote
CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:35187044
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE103224
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE103224
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:35187044
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3389/fsurg.2021.775194
sha256
sha256:2ee89a08127301e2c85f5696c6b16f069d5a43598185f6335ba60d2e1e6c46b2
bytes
63509
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3389/fsurg.2021.775194
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8850306
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE103224
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103224
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE103224
version
null
note
Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.
access_statement_kind
data_availability_statement
sample_accessions array · 8 items
[0]
GSM2758471
[1]
GSM2758472
[2]
GSM2758473
[3]
GSM2758474
[4]
GSM2758475
[5]
GSM2758476
[6]
GSM2758477
[7]
GSM2940098
sample_count
8
group_sizes
null
group_sizes_basis
null
platform
18573
taxon
Homo sapiens
title
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma
resolution_checked_at
2026-11-01T18:06:43Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE121810
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121810
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE121810
version
null
note
Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.
access_statement_kind
data_availability_statement
sample_accessions array · 29 items
[0]
GSM3447008
[1]
GSM3447009
[2]
GSM3447010
[3]
GSM3447011
[4]
GSM3447012
[5]
GSM3447013
[6]
GSM3447014
[7]
GSM3447015
[8]
GSM3447016
[9]
GSM3447017
[10]
GSM3447018
[11]
GSM3447019
[12]
GSM3447020
[13]
GSM3447021
[14]
GSM3447022
[15]
GSM3447023
[16]
GSM3447024
[17]
GSM3447025
[18]
GSM3447026
[19]
GSM3447027
[20]
GSM3447028
[21]
GSM3447029
[22]
GSM3447030
[23]
GSM3447031
[24]
GSM3447032
[25]
GSM3447033
[26]
GSM3447034
[27]
GSM3447035
[28]
GSM3447036
sample_count
29
group_sizes
null
group_sizes_basis
null
platform
21290
taxon
Homo sapiens
title
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
resolution_checked_at
2026-11-01T18:06:43Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 4 items
[0]
asset:data:geo:GSE103224 not downloaded
[1]
asset:data:geo:GSE103224 licence not read
[2]
asset:data:geo:GSE121810 not downloaded
[3]
asset:data:geo:GSE121810 licence not read
analysis object · 4 fields
state
complete
methods array · 3 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44.
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log-rank
[2] object · 10 fields
id
method-3
family
correlation_analysis
specific
pearson
label
Correlation analysis
dsl_operations array · 1 item
[0]
pearson_r
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
paired_numeric_columns
evidence object · 3 fields
score
0.8
band
high
quote
Pearson's correlation
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE121810
[1]
GSE103224
resolved_accessions array · 2 items
[0]
GSE121810
[1]
GSE103224
statements array · 1 item
[0]
Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.
basis
The paper names GSE121810, GSE103224 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 2 items
[0]
source:pmid:35187044
[1]
data:geo:GSE103224
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE103224
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T17:35:15Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
17856
completion_tokens
1770
cached_tokens
128
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:35187044
type
paper
label
pmid:35187044
[1] object · 3 fields
id
source:pmid:35187044
type
manuscript
label
PMID 35187044 full text
[2] object · 3 fields
id
data:geo:GSE103224
type
dataset
label
GEO GSE103224
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:35187044
type
paper
label
pmid:35187044
[1] object · 3 fields
id
source:pmid:35187044
type
manuscript
label
PMID 35187044 full text
[2] object · 3 fields
id
data:geo:GSE103224
type
dataset
label
GEO GSE103224
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-35187044
type
extraction
used array · 1 item
[0]
source:pmid:35187044
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE103224
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE103224
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:35187044
parent_hash
sha256:f78f4e1897f362397398c44adef5c3ace1c7550d0e6bc23aec4540d301e69a5b
fork_of
null
gaps array · 8 items
[0]
asset:data:geo:GSE103224 licence not read
[1]
asset:data:geo:GSE103224 not downloaded
[2]
asset:data:geo:GSE121810 licence not read
[3]
asset:data:geo:GSE121810 not downloaded
[4]
execution.not_run
[5]
review.human_critique
[6]
review.independent_reader
[7]
review.machine_critique
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
rna_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
and the Chinese Glioma Genome Atlas (CGGA), RNA-seq data with anatomic information of glioblasto
[1]
accessed through GSE121810, and single-cell RNA-seq data of GBM under accession GSE103224 were e
[2]
BM) from the Ivy Glioblastoma Atlas Project, RNA-sequencing (RNA-seq) data from recurrent GBM receiving
[3]
Glioblastoma Atlas Project, RNA-sequencing (RNA-seq) data from recurrent GBM receiving adjuvant
order_basis
paper_text_order:337
id
assay:1
[1] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44.
order_basis
consumes_earlier_output
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:35187044", "kind": "science-record", "revision": 5, "content_hash": "sha256:38ef21178018406a53c57c7d197b1d577c3e2aa66ea6dbe03585fbbd3fc5f2f3", "created_at": "2026-11-01T17:36:57Z", "updated_at": "2026-11-01T22:48:32Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression.", "doi": "10.3389/fsurg.2021.775194", "pmid": "35187044", "authors": ["Yong Xiao", "Kun Yang", "Zhen Wang", "Mengjie Zhao", "Yanxiang Deng", "Wei Ji", "Yuanjie Zou", "Chunfa Qian", "Yong Liu", "Hong Xiao", "Hongyi Liu"], "journal": "Frontiers in surgery", "year": 2021, "abstract": "BACKGROUND: Glioma is the most common primary brain tumor with a poor prognosis. Key genes that are negatively related to prognosis may provide the therapy targets to cure glioma. To clarify the role of CD44 in glioma, we explored its function at bulk-transcriptome, spatial and single-cell transcriptome levels.\nMETHODS: In total, expression profiles with survival data of whole-grade glioma from The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA), RNA-seq data with anatomic information of glioblastoma (GBM) from the Ivy Glioblastoma Atlas Project, RNA-sequencing (RNA-seq) data from recurrent GBM receiving adjuvant anti-PD-1 immunotherapy accessed through GSE121810, and single-cell RNA-seq data of GBM under accession GSE103224 were enrolled in this study. CD44-specific findings were further analyzed by R language.\nRESULTS: CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma. Meanwhile, CD44 predominantly expresses in GBM mesenchymal subtype, and gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses reveal that CD44 positively coexpressed genes are closely related to glioma immunity. Moreover, CD44+ cells mainly distribute in perinecrotic region with high expression of immune factors. At single-cell resolution, only malignant tumor cells, tumor-associated macrophages (TAMs), and T cells express CD44 in GBM. CD44+ malignant tumor cells are in mesenchymal-1-like (MES1-like) cellular state, and CD44+ TAMs are in M2 phenotype. CD44+ T cells have high expression of both PD-1 and PD-L1. CD44 and its directly interacted inhibitory immunomodulators are upregulated in patients with nonresponder recurrent GBM treated with PD-1 blockade therapy.\nCONCLUSION: Our work demonstrates that CD44, a new M2 TAM biomarker, is involved in immune suppressor and promote glioma progression in glioma microenvironment. These results expand our understanding of CD44-specific clinical and immune features in glioma.", "claims": [{"id": "claim-method", "statement": "Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35187044", "locator": "sections[4] \"Survival Analysis\" paragraph 2", "quote": "Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35187044", "locator": "sections[23] \"Data Availability Statement\" paragraph 2", "quote": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224."}], "state": "complete"}, {"id": "claim-target-result", "statement": "CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:35187044", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:35187044"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE103224"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE103224"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:35187044", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fsurg.2021.775194", "sha256": "sha256:2ee89a08127301e2c85f5696c6b16f069d5a43598185f6335ba60d2e1e6c46b2", "bytes": 63509, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fsurg.2021.775194", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8850306", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE103224", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103224", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE103224", "version": null, "note": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM2758471", "GSM2758472", "GSM2758473", "GSM2758474", "GSM2758475", "GSM2758476", "GSM2758477", "GSM2940098"], "sample_count": 8, "group_sizes": null, "group_sizes_basis": null, "platform": "18573", "taxon": "Homo sapiens", "title": "Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma", "resolution_checked_at": "2026-11-01T18:06:43Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE121810", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121810", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE121810", "version": null, "note": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM3447008", "GSM3447009", "GSM3447010", "GSM3447011", "GSM3447012", "GSM3447013", "GSM3447014", "GSM3447015", "GSM3447016", "GSM3447017", "GSM3447018", "GSM3447019", "GSM3447020", "GSM3447021", "GSM3447022", "GSM3447023", "GSM3447024", "GSM3447025", "GSM3447026", "GSM3447027", "GSM3447028", "GSM3447029", "GSM3447030", "GSM3447031", "GSM3447032", "GSM3447033", "GSM3447034", "GSM3447035", "GSM3447036"], "sample_count": 29, "group_sizes": null, "group_sizes_basis": null, "platform": "21290", "taxon": "Homo sapiens", "title": "Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma", "resolution_checked_at": "2026-11-01T18:06:43Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE103224 not downloaded", "asset:data:geo:GSE103224 licence not read", "asset:data:geo:GSE121810 not downloaded", "asset:data:geo:GSE121810 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44."}}, {"id": "method-2", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-3", "family": "correlation_analysis", "specific": "pearson", "label": "Correlation analysis", "dsl_operations": ["pearson_r"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["paired_numeric_columns"], "evidence": {"score": 0.8, "band": "high", "quote": "Pearson's correlation"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE121810", "GSE103224"], "resolved_accessions": ["GSE121810", "GSE103224"], "statements": ["Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224."], "basis": "The paper names GSE121810, GSE103224 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:35187044", "data:geo:GSE103224"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE103224"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T17:35:15Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 17856, "completion_tokens": 1770, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:35187044", "type": "paper", "label": "pmid:35187044"}, {"id": "source:pmid:35187044", "type": "manuscript", "label": "PMID 35187044 full text"}, {"id": "data:geo:GSE103224", "type": "dataset", "label": "GEO GSE103224"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:35187044", "type": "paper", "label": "pmid:35187044"}, {"id": "source:pmid:35187044", "type": "manuscript", "label": "PMID 35187044 full text"}, {"id": "data:geo:GSE103224", "type": "dataset", "label": "GEO GSE103224"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-35187044", "type": "extraction", "used": ["source:pmid:35187044"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE103224", "type": "accession_resolution", "used": ["data:geo:GSE103224"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:35187044", "parent_hash": "sha256:f78f4e1897f362397398c44adef5c3ace1c7550d0e6bc23aec4540d301e69a5b", "fork_of": null, "generation": 4}, "gaps": ["asset:data:geo:GSE103224 licence not read", "asset:data:geo:GSE103224 not downloaded", "asset:data:geo:GSE121810 licence not read", "asset:data:geo:GSE121810 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["and the Chinese Glioma Genome Atlas (CGGA), RNA-seq data with anatomic information of glioblasto", "accessed through GSE121810, and single-cell RNA-seq data of GBM under accession GSE103224 were e", "BM) from the Ivy Glioblastoma Atlas Project, RNA-sequencing (RNA-seq) data from recurrent GBM receiving", "Glioblastoma Atlas Project, RNA-sequencing (RNA-seq) data from recurrent GBM receiving adjuvant"], "order_basis": "paper_text_order:337", "id": "assay:1"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44."], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}